Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Broad Center for Mendelian Genomics, |
RCV001005021 | SCV001164586 | pathogenic | Leber congenital amaurosis 6 | 2018-12-03 | criteria provided, single submitter | research | The heterozygous p.Glu299SerfsTer21 variant in RPGRIP1 was identified by our study in the compound heterozygous state, with another likely pathogenic variant, in one individual with Leber congenital amaurosis. The presence of this variant in combination with a likely pathogenic variant and in an individual with Leber congenital amaurosis slightly increases the likelihood that the p.Glu299SerfsTer21 variant is pathogenic. The p.Glu299SerfsTer21 variant in RPGRIP1 has not been previously reported in individuals with Leber congenital amaurosis and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 299 and leads to a premature termination codon 21 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the RPGRIP1 gene is an established disease mechanism in autosomal recessive Leber congenital amaurosis. In summary, the clinical significance of the p.Glu299SerfsTer21 variant is pathogenic. Criteria applied: PM2, PVS1, PM3_Supporting (Richards 2015). |
Laboratory of Genetics in Ophthalmology, |
RCV001005021 | SCV001438575 | pathogenic | Leber congenital amaurosis 6 | no assertion criteria provided | research |